You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 16, 2024

CLINICAL TRIALS PROFILE FOR MGL-3196


✉ Email this page to a colleague

« Back to Dashboard


Clinical Trials for MGL-3196

Trial ID Title Status Sponsor Phase Summary
NCT02542969 ↗ Drug Interaction Study of MGL-3196 With Rosuvastatin and Simvastatin Completed Celerion Phase 1 The purpose of this study is to determine whether MGL-3196 alters the pharmacokinetics of rosuvastatin and/or simvastatin in healthy male subjects and female subjects not of child-bearing potential.
NCT02542969 ↗ Drug Interaction Study of MGL-3196 With Rosuvastatin and Simvastatin Completed Madrigal Pharmaceuticals, Inc. Phase 1 The purpose of this study is to determine whether MGL-3196 alters the pharmacokinetics of rosuvastatin and/or simvastatin in healthy male subjects and female subjects not of child-bearing potential.
NCT02749578 ↗ Drug Interaction Study of MGL-3196 With Atorvastatin Completed Celerion Phase 1 The purpose of this study is to determine whether MGL-3196 alters the pharmacokinetics of atorvastatin in healthy male subjects and female subjects not of child-bearing potential.
NCT02749578 ↗ Drug Interaction Study of MGL-3196 With Atorvastatin Completed Madrigal Pharmaceuticals, Inc. Phase 1 The purpose of this study is to determine whether MGL-3196 alters the pharmacokinetics of atorvastatin in healthy male subjects and female subjects not of child-bearing potential.
NCT02912260 ↗ Phase 2 Study of MGL-3196 in Patients With Non-Alcoholic Steatohepatitis (NASH) Unknown status Madrigal Pharmaceuticals, Inc. Phase 2 The primary objective of this study is to determine the effect of once-daily oral MGL-3196 on the percent change in hepatic fat fraction from baseline in patients with biopsy-proven Non-alcoholic Steatohepatitis (NASH).
NCT03038022 ↗ Study of MGL-3196 in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) Completed Madrigal Pharmaceuticals, Inc. Phase 2 The primary objective of this study is to determine the effect of once-daily oral MGL-3196 on the percent change from baseline in low-density lipoprotein cholesterol (LDL-C) in patients with Heterozygous Familial Hypercholesterolemia (HeFH).
NCT03220165 ↗ Radiolabeled Study to Determine the Mass Balance of [14C] MGL-3196 Completed Worldwide Clinical Trials Phase 1 The purpose of this study is determine in healthy males how MGL-3196 is metabolized using a radio-labeled version of MGL-3196.
>Trial ID >Title >Status >Phase >Summary

Clinical Trial Conditions for MGL-3196

Condition Name

Condition Name for
Intervention Trials
Healthy 6
NASH - Nonalcoholic Steatohepatitis 2
Non-Alcoholic Fatty Liver Disease 2
Heterozygous Familial Hypercholesterolemia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for
Intervention Trials
Non-alcoholic Fatty Liver Disease 5
Fatty Liver 5
Liver Diseases 3
Liver Cirrhosis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for MGL-3196

Trials by Country

Trials by Country for
Location Trials
United States 93
France 13
Belgium 6
Australia 5
United Kingdom 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for
Location Trials
Arizona 8
Texas 6
Florida 5
Virginia 4
North Carolina 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for MGL-3196

Clinical Trial Phase

Clinical Trial Phase for
Clinical Trial Phase Trials
Phase 3 3
Phase 2 2
Phase 1 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for
Clinical Trial Phase Trials
Completed 7
Recruiting 4
Unknown status 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for MGL-3196

Sponsor Name

Sponsor Name for
Sponsor Trials
Madrigal Pharmaceuticals, Inc. 12
Celerion 3
Worldwide Clinical Trials 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for
Sponsor Trials
Industry 15
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.